Epithelioid fibrous histiocytoma (EFH) is a distinctive cutaneous neoplasm with a relatively variable morphological appearance. Recently, it has been shown that this tumor is molecularly characterized by ALK gene fusions. We report three EFHs with unusual histological presentation represented by a prominent/predominant spindle cell proliferation arranged in a variably storiform/whirling architectural pattern with or without stromal sclerosis. One of the cases closely resembled cellular fibrous histiocytoma. All three cases were immunohistochemically ALK-positive and were analyzed for ALK gene rearrangements using a next-generation sequencing-based assay (FusionPlex Sarcoma Kit, ArcherDx). Three novel fusions, namely AP3D1::ALK, COL1A::ALK, and LRRFIP2::ALK, were detected and further confirmed by FISH in all 3 cases and RT-PCR in 1 case. All patients were elderly (62-63 years) and presented with a solitary polypoid lesion on the extremities. The awareness of these morphological variants is important since it entertains a wide and slightly different differential diagnosis than conventional EFH. We also presented evidence that a clear separation of EFH from BFH in all cases may not be as straightforward as previously thought. The consistent ALK immunoexpression and the continually expanding scale of ALK gene rearrangements provide a useful tool to distinguish EFH from its histologic mimics.

Bioptical Laboratory Ltd Pilsen Czech Republic

Department of Pathology Faculty of Medicine in Pilsen Charles University Pilsen Czech Republic

Department of Pathology University Hospital Campus Bio Medico Rome Italy

See more in PubMed

Jones EW, Cerio R, Smith NP (1989) Epithelioid cell histiocytoma: a new entity. Br J Dermatol 120:185–195 PubMed DOI

Kazakov DV, Kyrpychova L, Martinek P et al (2018) ALK gene fusions in epithelioid fibrous histiocytoma: a study of 14 cases, with new histopathological findings. Am J Dermatopathol 1–10

Doyle LA, Marino-Enriquez A, Fletcher CD, Hornick JL (2015) ALK rearrangement and overexpression in epithelioid fibrous histiocytoma. Mod Pathol 28(7):904–912 PubMed DOI

Dickson BC, Swanson D, Charames GS et al (2018) Epithelioid fibrous histiocytoma: molecular characterization of ALK fusion partners in 23 cases. Mod Pathol 31:753–762 PubMed DOI

Georgantzoglou N, Green D, Winnick KN et al (2022) Molecular investigation of ALK-rearranged epithelioid fibrous histiocytomas identifies CLTC as a novel fusion partner and evidence of fusion-independent transcription activation. Genes Chromosom Cancer 1‐10

Gomez CS, Calonje E, Fletcher C (1994) Epithelioid benign fibrous histiocytoma of skin: clinico-pathological analysis of 20 cases of a poorly known variant. Histopathology 24:123–129 DOI

Glusac EJ, McNiff JM (1999) Epithelioid cell histiocytoma: a simulant of vascular and melanocytic neoplasms. Am J Dermatopathol 21:1–7 PubMed DOI

Jedrych J, Nikiforova M, Kennedy TF et al (2015) Epithelioid cell histiocytoma of the skin with clonal ALK gene rearrangement resulting in VCL-ALK and SQSTM1-ALK gene fusions. Br J Dermatol 172:1427–1429 PubMed DOI

Miura Y, Misago N, Narisawa Y (2005) Epithelioid cell histiocytoma with underlying artery damage. J Dermatol 32:721–726 PubMed DOI

Murigu T, Bhatt N, Miller K, Palmer A, Melegh Z (2018) Spindle cell predominant epithelioid fibrous histiocytoma. Histopathology 72(7):1233–1236 PubMed DOI

Lee J (2007) Epithelioid cell histiocytoma with granular cells (another nonneural granular cell neoplasm). Am J Dermatopathol 29(5):475–476 PubMed DOI

Martinez AP, Zou Y, Billings SD et al (2018) “Chondroblastoma-like” epithelioid fibrous histiocytoma: a previously undescribed and potentially confusing variant. J Cutan Pathol 45:99–103 PubMed DOI

Creytens D, Ferdinande L, Van Dorpe J (2017) ALK rearrangement and overexpression in an unusual cutaneous epithelioid tumor with a peculiar whorled “perineurioma-like” growth pattern: epithelioid fibrous histiocytoma. Appl Immunohistochem Mol Morphol 25:e48 DOI

Chang KTE, Tay AZE, Kuick CH, Chen H, Algar E, Taubenheim N, Campbell J, Mechinaud F, Campbell M, Super L, Chantranuwat C, Yuen ST, Chan JKC, Chow CW (2019) ALK-positive histiocytosis: an expanded clinicopathologic spectrum and frequent presence of KIF5B-ALK fusion. Mod Pathol 32(5):598–608 PubMed DOI

WHO (2018) Classification of Skin Tumours. 4th ed. Lyon, France: World Health Organization

Płaszczyca A, Nilsson J, Magnusson L, Brosjö O, Larsson O, Vult von Steyern F, Domanski HA, Lilljebjörn H, Fioretos T, Tayebwa J, Mandahl N, Nord KH, Mertens F (2014) Fusions involving protein kinase C and membrane-associated proteins in benign fibrous histiocytoma. Int J Biochem Cell Biol 53:475–81 PubMed DOI

Walther C, Hofvander J, Nilsson J, Magnusson L, Domanski HA, Gisselsson D, Tayebwa J, Doyle LA, Fletcher CD, Mertens F (2015) Gene fusion detection in formalin-fixed paraffin-embedded benign fibrous histiocytomas using fluorescence in situ hybridization and RNA sequencing. Lab Invest 95(9):1071–1076 PubMed DOI

Panagopoulos I, Gorunova L, Bjerkehagen B, Lobmaier I, Heim S (2015) LAMTOR1-PRKCD and NUMA1-SFMBT1 fusion genes identified by RNA sequencing in aneurysmal benign fibrous histiocytoma with t(3;11)(p21;q13). Cancer Genet 208(11):545–551 PubMed DOI

Dermawan JK, Azzato EM, Goldblum JR, Rubin BP, Billings SD, Ko JS (2021) Superficial ALK-rearranged myxoid spindle cell neoplasm: a cutaneous soft tissue tumor with distinctive morphology and immunophenotypic profile. Mod Pathol 34(9):1710–1718 PubMed DOI

Rapini RP, Golitz LE (1989) Sclerotic fibromas of the skin. J Am Acad Dermatol 20(2 Pt 1):266–271 PubMed DOI

Pujol RM, de Castro F, Schroeter AL, Su WP (1996) Solitary sclerotic fibroma of the skin: a sclerotic dermatofibroma? Am J Dermatopathol 18(6):620–624 PubMed DOI

Fetsch JF, Miettinen M (1997) Sclerosing perineurioma: a clinicopathologic study of 19 cases of a distinctive soft tissue lesion with a predilection for the fingers and palms of young adults. Am J Surg Pathol 21(12):1433–1442 PubMed DOI

Robson AM, Calonje E (2000) Cutaneous perineurioma: a poorly recognized tumour often misdiagnosed as epithelioid histiocytoma. Histopathology 37(4):332–339 PubMed DOI

Doyle LA, Fletcher CD (2011) EMA positivity in epithelioid fibrous histiocytoma: a potential diagnostic pitfall. J Cutan Pathol 38(9):697–703 PubMed DOI

Folpe AL, Billings SD, McKenney JK, Walsh SV, Nusrat A, Weiss SW (2002) Expression of claudin-1, a recently described tight junction-associated protein, distinguishes soft tissue perineurioma from potential mimics. Am J Surg Pathol 26(12):1620–1626 PubMed DOI

Hirose T, Tani T, Shimada T, Ishizawa K, Shimada S, Sano T (2003) Immunohistochemical demonstration of EMA/Glut1-positive perineurial cells and CD34-positive fibroblastic cells in peripheral nerve sheath tumors. Mod Pathol 16(4):293–298 PubMed DOI

Evans HL (2011) Low-grade fibromyxoid sarcoma: a clinicopathologic study of 33 cases with long-term follow-up. Am J Surg Pathol 35(10):1450–1462 PubMed DOI

Doyle LA, Möller E, Dal Cin P, Fletcher CD, Mertens F, Hornick JL (2011) MUC4 is a highly sensitive and specific marker for low-grade fibromyxoid sarcoma. Am J Surg Pathol 35(5):733–741 PubMed DOI

Lau PP, Lui PC, Lau GT, Yau DT, Cheung ET, Chan JK (2013) EWSR1-CREB3L1 gene fusion: a novel alternative molecular aberration of low-grade fibromyxoid sarcoma. Am J Surg Pathol 37(5):734–738 PubMed DOI

LeBoit PE, Yen TS, Wintroub B (1986) The evolution of lesions in erythema elevatum diutinum. Am J Dermatopathol 8(5):392–402 PubMed DOI

Yiannias JA, el-Azhary RA, Gibson LE (1992) Erythema elevatum diutinum a clinical and histopathologic study of 13 patients. J Am Acad Dermatol 26(1):38–44 PubMed DOI

High WA, Hoang MP, Stevens K, Cockerell CJ (2003) Late-stage nodular erythema elevatum diutinum. J Am Acad Dermatol 49(4):764–767 PubMed DOI

Mariño-Enríquez A, Dal Cin P (2013) ALK as a paradigm of oncogenic promiscuity: different mechanisms of activation and different fusion partners drive tumors of different lineages. Cancer Genet 206(11):357–373 PubMed DOI

Mohammed M, Al-Hashmi N, Al-Rashdi S, Al-Sukaiti N, Al-Adawi K, Al-Riyami M, Al-Maawali A (2019) Biallelic mutations in AP3D1 cause Hermansky-Pudlak syndrome type 10 associated with immunodeficiency and seizure disorder. Eur J Med Genet 62(11):103583 PubMed DOI

Ammann S, Schulz A, Krägeloh-Mann I et al (2016) Mutations in AP3D1 associated with immunodeficiency and seizures define a new type of Hermansky-Pudlak syndrome. Blood 127(8):997–1006 PubMed DOI

Liu J, Bang AG, Kintner C, Orth AP, Chanda SK, Ding S, Schultz PG (2005) Identification of the Wnt signaling activator leucine-rich repeat in Flightless interaction protein 2 by a genome-wide functional analysis. Proc Natl Acad Sci USA 102(6):1927–1932 PubMed DOI PMC

Dai P, Jeong SY, Yu Y, Leng T, Wu W, Xie L, Chen X (2009) Modulation of TLR signaling by multiple MyD88-interacting partners including leucine-rich repeat Fli-I-interacting proteins. J Immunol 182(6):3450–3460 PubMed DOI

Jin J, Yu Q, Han C et al (2013) LRRFIP2 negatively regulates NLRP3 inflammasome activation in macrophages by promoting flightless-Imediated caspase-1 inhibition. Nat Commun 4:20 DOI

Pinheiro M, Pinto C, Peixoto A et al (2011) A novel exonic rearrangement affecting MLH1 and the contiguous LRRFIP2 is a founder mutation in Portuguese Lynch syndrome families. Genet Med 13(10):895–902 PubMed DOI

Dalgleish R (1997) The human type I collagen mutation database. Nucleic Acids Res 25(1):181–187 PubMed DOI PMC

Hwang SJ, Ha GH, Seo WY, Kim CK, Kim K, Lee SB (2020) Human collagen alpha-2 type I stimulates collagen synthesis, wound healing, and elastin production in normal human dermal fibroblasts (HDFs). BMB Rep 53(10):539–544 PubMed DOI PMC